Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesVascular Remodelling and Mesenchymal Transition in Systemic SclerosisBlocking the 4-1BB Pathway Ameliorates Crystalline Silica-induced Lung Inflammation and Fibrosis in MiceFine-tuning vascular fate during endothelial-mesenchymal transition.Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.Pathogenesis of systemic sclerosis-current concept and emerging treatments.Activation of Nrf2 Attenuates Pulmonary Vascular Remodeling via Inhibiting Endothelial-to-Mesenchymal Transition: an Insight from a Plant Polyphenol.Nox, Reactive Oxygen Species and Regulation of Vascular Cell Fate.The Role of Stem Cells in Dupuytren's Disease: A Review.The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis.A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic SclerosisAn orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
P2860
Q26748338-AAD0447C-257E-4C4C-9217-825476B46F15Q26749091-CBDC08AF-6FBF-4250-9D04-ADD27AEF65ACQ29048610-EBAC3C2A-A790-4E5C-8069-E1F6B80E457DQ30275793-1709D6F0-B646-49A5-99C1-890AE34CAED6Q36119874-744BE073-EEC7-44A8-900F-CCEE36F4239DQ37316247-F9D8113B-DA2D-4BF1-9480-0FAA26736D19Q39233347-2E63090C-E46E-4823-88CF-5ED2617839CAQ39294794-227D020E-6B1A-4770-8DE7-E36A379A2C73Q41035889-19B269F4-B55E-4012-BC8F-DE392B63D29DQ46261737-E2ACC76C-6501-4B16-9042-4883A8FB6213Q55208808-8905D06F-202F-433F-B107-DEBEB7CC3C94Q55402074-4B243B9E-C792-4E80-A9C7-B7F8358CEA59Q57072741-DD745F1F-B670-4259-B23A-4BA13840B9DCQ58797878-14C9550C-FE47-4EB2-9F0D-44B7AFCA1FCC
P2860
Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Endothelial to mesenchymal tra ...... hypertension. Myth or reality?
@en
type
label
Endothelial to mesenchymal tra ...... hypertension. Myth or reality?
@en
prefLabel
Endothelial to mesenchymal tra ...... hypertension. Myth or reality?
@en
P2860
P921
P1433
P1476
Endothelial to mesenchymal tra ...... hypertension. Myth or reality?
@en
P2093
Sergio A Jimenez
Sonsoles Piera-Velazquez
P2860
P356
10.1016/J.MATBIO.2016.01.012
P577
2016-01-22T00:00:00Z